Palladio Biosciences logo

Palladio Biosciences jobs and careers

Horsham, PA, United States

About Palladio Biosciences

Palladio Biosciences, Inc., is a Centessa company. Their first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes numerous fluid-filled cysts to grow in both kidneys. It is a life-limiting, chronic and progressive disease.

Founded in 2015 by Lorenzo Pellegrini.

Founded
2015
Employees
1 to 10
Total funding
$20M
Headquarters
Horsham

Leadership

The top of Palladio Biosciences's org chart, with how many people report into each leader.

MAPhoto of Marcus Abraitis

Marcus Abraitis

VP of Finance

LHPhoto of Linda C. Hogan

Linda C. Hogan

CBO

RDPhoto of Ron Dadino

Ron Dadino

VP of CMC & Manufacturing Head of Quality

AMPhoto of Amy Murnane

Amy Murnane

VP of Project Management

PV

Petia Vladimirova

Director Clinical Operations